Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rec

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received a consensus rating of “N/A” from the zero research firms that are covering the stock, MarketBeat Ratings reports. NMRA has been the subject of a number of research reports. Royal Bank of Canada assumed coverage on Neumora Therapeutics in a research note on […]

Related Keywords

Canada , William Blair , Stifel Nicolaus , Neumora Therapeutics Inc , Nasdaq , Arch Venture Partners Xii Llc , Royal Bank , Neumora Therapeutics Company Profile , Jpmorgan Chase Co , Amgen Inc , Neumora Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Trading Down , Arch Venture Partners Xii , Get Free , Neumora Therapeutics Daily , Nasdaq Nmra , Nmra , Medical , Ratings , Consensus ,